VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NTLA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NTLAIntellia Therapeutics, Inc.
$11.35$1.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNTLAQuarterly Financials

Intellia Therapeutics, Inc. (NTLA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Intellia Therapeutics, Inc. (NTLA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

NTLA Income Statement

Quarterly statement

NTLA Income Statement

Intellia Therapeutics, Inc. (NTLA) annual income statement — 12-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue7.16M7.66M15.05M23.02M13.78M14.24M16.63M12.87M9.11M6.96M28.93M-1.92M11.99M13.59M12.61M13.57M13.27M14.03M11.25M12.85M
Revenue Growth %-48.03%-46.23%-9.5%78.79%51.27%104.76%-42.54%771.57%-24.02%-48.82%129.53%-114.12%-9.6%-3.11%12.03%5.59%84.15%114.2%74.58%94.91%
Cost of Goods Sold002.2M6.01M78.95M80.53M0116.88M109.17M2.6M2.51M2.47M2.29M115.28M97.12M100.03M96.65M90.2M133.09M71.16M
COGS % of Revenue--14.63%26.13%572.84%565.34%-907.85%1198.27%37.36%8.68%-128.64%19.1%847.99%770.39%737.01%728.56%642.9%1182.86%553.61%
Gross Profit7.16M7.66M12.85M17M-65.17M-66.29M16.63M-104M-100.06M4.36M26.42M-4.38M9.7M-101.68M-84.51M-86.46M-83.39M-76.17M-121.84M-58.31M
Gross Margin %100%100%85.37%73.87%-472.84%-465.34%100%-807.85%-1098.27%62.64%91.32%228.64%80.9%-747.99%-670.39%-637.01%-628.56%-542.9%-1082.86%-453.61%
Gross Profit Growth %110.99%111.55%-22.74%116.35%34.87%-1621.06%-37.07%-2272.87%-1131.36%104.29%131.27%94.93%111.64%-33.5%30.64%-48.29%-56.5%-45.54%-271.12%-84.31%
Operating Expenses129.49M120.42M113.38M115.71M46.31M43.71M137.43M32.44M44.71M143.4M140.43M135.51M140.81M30.65M27.45M23.63M22.14M22.13M22.4M22.11M
OpEx % of Revenue1807.73%1572.25%753.44%502.72%336.02%306.83%826.57%252.01%490.69%2061.25%485.32%-7068.81%1174.19%225.48%217.74%174.07%166.93%157.75%199.1%171.99%
Selling, General & Admin46.14M37.82M34.84M33.08M46.31M43.71M29.01M32.44M44.71M31.79M31.09M28.99M29.4M30.65M27.45M23.63M22.14M22.13M22.4M22.11M
SG&A % of Revenue644.17%493.85%231.55%143.7%336.02%306.83%174.46%252.01%490.69%456.99%107.45%-1512.47%245.19%225.48%217.74%174.07%166.93%157.75%199.1%171.99%
Research & Development83.35M82.59M80.74M88.65M94.75M97.03M108.43M116.88M123.38M111.61M109.33M108.98M113.7M115.28M97.12M100.03M96.65M90.2M133.09M71.16M
R&D % of Revenue1163.56%1078.4%536.53%385.16%687.47%681.19%652.11%907.85%1354.19%1604.25%377.86%-5684.98%948.1%847.99%770.39%737.01%728.56%642.9%1182.86%553.61%
Other Operating Expenses00-1000K-1000K-1000K-1000K0-1000K-1000K00-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-122.33M-112.76M-100.53M-98.71M-111.48M-110M-120.81M-136.45M-144.77M-139.04M-114M-139.89M-131.11M-132.33M-111.96M-110.09M-105.53M-98.3M-144.25M-80.42M
Operating Margin %-1707.73%-1472.25%-668.08%-428.86%-808.86%-772.17%-726.57%-1059.86%-1588.96%-1998.61%-394%7297.44%-1093.29%-973.47%-888.13%-811.07%-795.49%-700.65%-1281.96%-625.6%
Operating Income Growth %-9.73%-2.51%16.78%27.66%23%20.89%-5.97%2.46%-10.42%-5.07%-1.83%-27.07%-24.24%-34.62%22.38%-36.9%-46.58%-42.43%-210.71%-89.66%
EBITDA-126.87M-110.68M-98.33M-98.33M-106.54M-107.52M-118.31M-133.88M-142.16M-136.44M-111.49M-137.43M-128.82M-130.16M-109.91M-108.06M-103.58M-96.46M-142.49M-78.53M
EBITDA Margin %-1771.24%-1445.07%-653.44%-427.22%-773.04%-754.81%-711.55%-1039.93%-1560.33%-1961.25%-385.32%7168.81%-1074.19%-957.51%-871.87%-796.11%-780.79%-687.56%-1266.37%-610.98%
EBITDA Growth %-19.08%-2.94%16.89%26.55%25.06%21.2%-6.12%2.58%-10.36%-4.82%-1.44%-27.18%-24.36%-34.94%22.87%-37.59%-47.54%-43.16%-217.82%-92.5%
D&A (Non-Cash Add-back)02.08M2.2M377K4.94M2.47M2.5M2.57M2.61M2.6M2.51M2.47M2.29M2.17M2.05M2.03M1.95M1.84M1.75M1.88M
EBIT-126.87M-106.63M-96.23M-95.79M-101.32M-101.25M-114.33M-128.9M-135.71M-146.97M-107.44M-139.89M-131.11M-132.33M-111.96M-110.09M-105.53M-98.3M-144.25M-80.42M
Net Interest Income5.23M5.8M5.21M6.48M6.71M7.4M8.6M10.63M12.12M12.42M12.63M12.46M12.74M12.65M11.98M5.35M1.95M703K540K503K
Interest Income5.84M5.8M5.21M6.48M6.71M7.4M8.6M10.63M12.12M12.42M12.63M12.46M12.74M12.65M11.98M5.35M1.95M703K540K503K
Interest Expense611K0000000000000000000
Other Income/Expense-5.16M6.13M4.3M2.92M10.15M8.74M6.48M7.55M9.06M-7.93M6.57M7.73M8.88M8.65M8.83M-3.32M-7.7M-2.38M-2.63M-822K
Pretax Income-127.48M-106.63M-96.23M-95.79M-101.32M-101.25M-114.33M-128.9M-135.71M-146.97M-107.44M-132.16M-122.22M-123.68M-103.13M-113.41M-113.23M-100.68M-146.87M-81.24M
Pretax Margin %-1779.77%-1392.27%-639.49%-416.15%-735.19%-710.81%-687.61%-1001.23%-1489.54%-2112.62%-371.3%6894.16%-1019.21%-909.82%-818.07%-835.53%-853.53%-717.59%-1305.3%-632%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-127.48M-106.63M-96.23M-95.79M-101.32M-101.25M-114.33M-128.9M-135.71M-146.97M-107.44M-132.16M-122.22M-123.68M-103.13M-113.41M-113.23M-100.68M-146.87M-81.24M
Net Margin %-1779.77%-1392.27%-639.49%-416.15%-735.19%-710.81%-687.61%-1001.23%-1489.54%-2112.62%-371.3%6894.16%-1019.21%-909.82%-818.07%-835.53%-853.53%-717.59%-1305.3%-632%
Net Income Growth %-25.82%-5.31%15.83%25.69%25.34%31.11%-6.42%2.47%-11.04%-18.83%-4.18%-16.54%-7.94%-22.85%29.79%-39.6%-58.04%-46.32%-217.87%-92.54%
Net Income (Continuing)-127.48M-106.63M-96.23M-95.79M-101.32M-101.25M-114.33M-128.9M-135.71M-146.97M-107.44M-132.16M-122.22M-123.68M-103.13M-113.41M-113.23M-100.68M-146.87M-81.24M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.91-0.80-0.81-0.83-0.92-0.98-1.10-1.27-1.34-1.52-1.12-1.46-1.38-1.40-1.17-1.40-1.49-1.33-1.96-1.09
EPS Growth %1.09%18.37%26.36%34.65%31.34%35.53%1.79%13.01%2.9%-8.38%4.27%-4.57%7.31%-5.63%40.45%-27.92%-53.49%-31.47%-184.75%-58.19%
EPS (Basic)-0.91-0.80-0.81-0.83-0.92-0.98-1.10-1.27-1.34-1.52-1.12-1.46-1.38-1.40-1.17-1.40-1.49-1.33-1.96-1.09
Diluted Shares Outstanding140.19M133.48M118.49M108.38M110.19M103.73M103.5M101.86M101M96.97M95.5M90.46M88.64M88.19M87.77M81.22M76.05M75.82M74.75M74.43M
Basic Shares Outstanding140.19M133.48M118.49M108.38M110.19M103.73M103.5M101.86M101M96.97M95.5M90.46M88.64M88.19M87.77M81.22M76.05M75.82M74.75M74.43M
Dividend Payout Ratio--------------------